nodes	percent_of_prediction	percent_of_DWPC	metapath
Neomycin—Framycetin—CXCR4—sarcoma	0.324	1	CrCbGaD
Neomycin—Ototoxicity—Thiotepa—sarcoma	0.13	0.193	CcSEcCtD
Neomycin—Nephropathy toxic—Mitoxantrone—sarcoma	0.0393	0.0582	CcSEcCtD
Neomycin—Secondary infection—Epirubicin—sarcoma	0.0358	0.053	CcSEcCtD
Neomycin—Secondary infection—Doxorubicin—sarcoma	0.0332	0.049	CcSEcCtD
Neomycin—Nephropathy toxic—Etoposide—sarcoma	0.0327	0.0484	CcSEcCtD
Neomycin—Sensitisation—Epirubicin—sarcoma	0.0295	0.0436	CcSEcCtD
Neomycin—Sensitisation—Doxorubicin—sarcoma	0.0273	0.0404	CcSEcCtD
Neomycin—Viral infection—Mitoxantrone—sarcoma	0.025	0.037	CcSEcCtD
Neomycin—Swelling—Mitoxantrone—sarcoma	0.0186	0.0275	CcSEcCtD
Neomycin—Swelling—Etoposide—sarcoma	0.0155	0.0229	CcSEcCtD
Neomycin—Viral infection—Epirubicin—sarcoma	0.0117	0.0172	CcSEcCtD
Neomycin—Erythema—Thiotepa—sarcoma	0.0114	0.0169	CcSEcCtD
Neomycin—Erythema—Dactinomycin—sarcoma	0.0114	0.0168	CcSEcCtD
Neomycin—Viral infection—Doxorubicin—sarcoma	0.0108	0.016	CcSEcCtD
Neomycin—Erythema—Mitoxantrone—sarcoma	0.00988	0.0146	CcSEcCtD
Neomycin—Infection—Thiotepa—sarcoma	0.00928	0.0137	CcSEcCtD
Neomycin—Infection—Dactinomycin—sarcoma	0.00921	0.0136	CcSEcCtD
Neomycin—Anaphylactic shock—Vincristine—sarcoma	0.00828	0.0122	CcSEcCtD
Neomycin—Infection—Vincristine—sarcoma	0.00822	0.0122	CcSEcCtD
Neomycin—Anaphylactic shock—Mitoxantrone—sarcoma	0.00806	0.0119	CcSEcCtD
Neomycin—Infection—Mitoxantrone—sarcoma	0.00801	0.0118	CcSEcCtD
Neomycin—Hypersensitivity—Thiotepa—sarcoma	0.00688	0.0102	CcSEcCtD
Neomycin—Hypersensitivity—Dactinomycin—sarcoma	0.00683	0.0101	CcSEcCtD
Neomycin—Anaphylactic shock—Etoposide—sarcoma	0.00671	0.00992	CcSEcCtD
Neomycin—Infection—Etoposide—sarcoma	0.00666	0.00985	CcSEcCtD
Neomycin—Pruritus—Thiotepa—sarcoma	0.00661	0.00977	CcSEcCtD
Neomycin—Diarrhoea—Thiotepa—sarcoma	0.00639	0.00945	CcSEcCtD
Neomycin—Diarrhoea—Dactinomycin—sarcoma	0.00634	0.00937	CcSEcCtD
Neomycin—Hypersensitivity—Vincristine—sarcoma	0.0061	0.00902	CcSEcCtD
Neomycin—Hypersensitivity—Mitoxantrone—sarcoma	0.00594	0.00878	CcSEcCtD
Neomycin—Vomiting—Thiotepa—sarcoma	0.00594	0.00878	CcSEcCtD
Neomycin—Vomiting—Dactinomycin—sarcoma	0.00589	0.00871	CcSEcCtD
Neomycin—Diarrhoea—Vincristine—sarcoma	0.00566	0.00838	CcSEcCtD
Neomycin—Nausea—Thiotepa—sarcoma	0.00555	0.0082	CcSEcCtD
Neomycin—Diarrhoea—Mitoxantrone—sarcoma	0.00552	0.00816	CcSEcCtD
Neomycin—Nausea—Dactinomycin—sarcoma	0.0055	0.00814	CcSEcCtD
Neomycin—Vomiting—Vincristine—sarcoma	0.00526	0.00778	CcSEcCtD
Neomycin—Vomiting—Mitoxantrone—sarcoma	0.00513	0.00758	CcSEcCtD
Neomycin—Hypersensitivity—Etoposide—sarcoma	0.00494	0.00731	CcSEcCtD
Neomycin—Nausea—Vincristine—sarcoma	0.00492	0.00727	CcSEcCtD
Neomycin—Nausea—Mitoxantrone—sarcoma	0.00479	0.00708	CcSEcCtD
Neomycin—Pruritus—Etoposide—sarcoma	0.00474	0.00702	CcSEcCtD
Neomycin—Erythema—Epirubicin—sarcoma	0.00461	0.00681	CcSEcCtD
Neomycin—Diarrhoea—Etoposide—sarcoma	0.00459	0.00678	CcSEcCtD
Neomycin—Vomiting—Etoposide—sarcoma	0.00426	0.0063	CcSEcCtD
Neomycin—Erythema—Doxorubicin—sarcoma	0.00426	0.0063	CcSEcCtD
Neomycin—Nausea—Etoposide—sarcoma	0.00398	0.00589	CcSEcCtD
Neomycin—Anaphylactic shock—Epirubicin—sarcoma	0.00376	0.00556	CcSEcCtD
Neomycin—Infection—Epirubicin—sarcoma	0.00373	0.00552	CcSEcCtD
Neomycin—Anaphylactic shock—Doxorubicin—sarcoma	0.00348	0.00514	CcSEcCtD
Neomycin—Infection—Doxorubicin—sarcoma	0.00346	0.00511	CcSEcCtD
Neomycin—Hypersensitivity—Epirubicin—sarcoma	0.00277	0.0041	CcSEcCtD
Neomycin—Pruritus—Epirubicin—sarcoma	0.00266	0.00393	CcSEcCtD
Neomycin—Diarrhoea—Epirubicin—sarcoma	0.00257	0.0038	CcSEcCtD
Neomycin—Hypersensitivity—Doxorubicin—sarcoma	0.00256	0.00379	CcSEcCtD
Neomycin—Pruritus—Doxorubicin—sarcoma	0.00246	0.00364	CcSEcCtD
Neomycin—Vomiting—Epirubicin—sarcoma	0.00239	0.00353	CcSEcCtD
Neomycin—Diarrhoea—Doxorubicin—sarcoma	0.00238	0.00352	CcSEcCtD
Neomycin—Nausea—Epirubicin—sarcoma	0.00223	0.0033	CcSEcCtD
Neomycin—Vomiting—Doxorubicin—sarcoma	0.00221	0.00327	CcSEcCtD
Neomycin—Nausea—Doxorubicin—sarcoma	0.00207	0.00305	CcSEcCtD
